NCT01875718View on ClinicalTrials.gov

A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Premenstrual Dysphoric Disorder
Interventions
DRUG

UC1010

DRUG

Placebo

Trial Locations (1)

17165

Umecrine Mood AB, Solna

All Listed Sponsors
lead

Umecrine Mood AB

INDUSTRY

NCT01875718 - A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) | Biotech Hunter | Biotech Hunter